Bio3 Research srl
Condividi
Bio3 Research a Preclinical Stage Development Company is seeking for Partners who may be interested in developing new compounds in the field of HMGB1 induced Cardiovascular pathologies (restenosis, artherial stenosis, atherosclerotic plaque progression, vasculitis) and in the field of regeneration of damaged Connective Tissues via use of HMGB1 wild proteine and/or its fragments in wound healing,
We are pleased to inform that the Dietary Supplement Biocysan ( L-Cysteine Pulse Release tablet) will be launched in Canada January 2015.The Product is patented in the USA,Canada,Mexico,Europe and Japan for use in Chronic Kidney Disease patients suffering of Anemia due to low levels of Glutathione and to countreact oxidative stress
17/06/2013
We are pleased to inform that on June 17th a Biocysan project has gone live on Crowd Funding Medstartr Platform specialized in Life Science projects please refer to the following link:
http://www.medstartr.com/projects/165-biocysan
Biocysan®
www.medstartr.com
,Bio3 Research needs $500,000 for 1 clinical study to confirm Biocysan®’s (L-Cysteine) anti-anemic role in Chronic Kidney Disease patients
Biocysan® ,Bio3 Research needs $500,000 for 1 clinical study to confirm Biocysan®’s (L-Cysteine) anti-anemic role in Chronic Kidney Disease patients
Clicca qui per richiedere la tua inserzione sponsorizzata.
Sito Web
Indirizzo
Via Della Moscova 6/8
Milan
20121
